Publications by authors named "Nicholas B H Ng"

This study aimed to explore Singaporean fathers' perceived influence over their children's eating habits. A descriptive qualitative study design was used. Convenience sampling was used to recruit fathers of children aged 3-21 years old from a general paediatric outpatient clinic in a tertiary public hospital.

View Article and Find Full Text PDF

Objectives: In Singapore, diabetes imposes a huge population health and economic burden. Despite that, there is paucity of evidence on the health economics of screening programs for type 2 diabetes, especially in the context of screening after gestational diabetes (GDM). The objective of this study is to assess cost-effectiveness of universal lifelong screening for type 2 diabetes after GDM, which is supported by current guidelines, compared with elective screening where 54% of mothers with GDM undertake one-off screening.

View Article and Find Full Text PDF

A 3-week-old neonate with glucose-6-phosphate dehydrogenase (G6PD) deficiency and primary lactic acidosis developed haemolytic jaundice and methaemoglobinaemia following treatment with dichloroacetate (DCA), a standard treatment for primary lactic acidosis. While this mechanism has been reported in the sheep model, it has not been described in humans. Our case reinforces the uncommon observation that a G6PD-deficient individual experiencing oxidative stress may develop concurrent methaemoglobinaemia.

View Article and Find Full Text PDF
Article Synopsis
  • Extended work hours and night shifts in healthcare can negatively impact physicians' sleep, well-being, and patient care, suggesting that alternative work schedules with shorter hours may help alleviate these problems.
  • An observational study tracked interns at a Singapore hospital for 8 weeks to compare the effects of irregular, extended shifts versus more regular, restricted-hour schedules on sleep, well-being, and cognitive performance.
  • Results indicated that participant well-being and sleep patterns varied significantly between those on irregular call schedules and those on a float schedule, highlighting the potential benefits of more predictable work hours for healthcare professionals.
View Article and Find Full Text PDF
Article Synopsis
  • The study looked at how atopic dermatitis (AD), a skin condition, can affect children's growth in height.
  • Researchers checked a lot of articles to see if kids with AD were shorter than those without, and found mixed results: some studies linked AD to being shorter, while others did not.
  • They found that kids with more severe AD, those who had it from a young age, had trouble sleeping, or had certain diet restrictions were more likely to have growth problems.
View Article and Find Full Text PDF
Article Synopsis
  • Non-alcoholic fatty liver disease (NAFLD), now often referred to as metabolic dysfunction-associated fatty liver disease (MAFLD), is prevalent among children and teens with obesity and is linked to metabolic syndrome factors like insulin resistance.
  • A consensus of 65 international experts was reached through surveys to create recommendations covering various aspects of pediatric MAFLD, including its causes, epidemiology, and treatment strategies.
  • The final consensus aims to enhance clinical outcomes and life quality for affected youth, highlighting the importance of standardized diagnosis and treatment methods.
View Article and Find Full Text PDF

Obstructive sleep apnea (OSA) is a prevalent complication that affects up to 60% of children and adolescents with obesity. It is associated with poorer cardiometabolic outcomes and neurocognitive deficits. Appropriate screening and intervention for OSA are crucial in the management of children with obesity.

View Article and Find Full Text PDF

Hypothalamic obesity does not respond well to conventional interventions for obesity. GLP-1 receptor agonists have mechanisms independent of the hypothalamus which may be potentially beneficial for managing hypothalamic obesity. This systematic review summarizes the efficacy and safety of GLP-1 receptor agonists use in hypothalamic obesity.

View Article and Find Full Text PDF

The rise in prevalence of childhood obesity is paralleled by an increase in obesity-related metabolic complications, which add significantly to the population burden of cardiovascular morbidity in the long term. Early detection of obesity-related metabolic complications through appropriate screening strategies forms a crucial aspect of obesity management. We performed a scoping review of international and national guidelines on the management of pediatric obesity to evaluate the recommendations on screening for metabolic complications, namely, hypertension, diabetes, dyslipidemia, and non-alcoholic fatty liver disease.

View Article and Find Full Text PDF

Background: Singapore was one of the first countries to begin COVID-19 vaccination with the BNT162b2 vaccine for adolescents aged 12-18 years. This study evaluates the incidence of COVID-19 vaccine related attendances to a Pediatric Emergency Department (PED) to understand post-vaccination health behaviors among adolescents.

Methods: This was a retrospective review of electronic medical records over a 4 month period, from the start of the adolescent vaccination drive to when more than 85% of this group had been fully vaccinated.

View Article and Find Full Text PDF

Objective: The mainstay management of hyperphagia and obesity in Prader-Willi syndrome (PWS) relies on dietary restrictions, strict supervision and behavioural modifications, which can be stressful for the patient and caregiver. There is no established pharmacological strategy to manage this aspect of PWS. Theoretically, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP1-RA) used in patients with obesity and type 2 diabetes mellitus (T2DM) may be efficacious in weight and glycaemic control of PWS patients.

View Article and Find Full Text PDF

Objective: Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity.

Design: A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions.

Setting: Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database.

View Article and Find Full Text PDF